Pediatric Drugs

Papers
(The H4-Index of Pediatric Drugs is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents53
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus47
The Role of Probiotics in the Prevention and Treatment of Atopic Dermatitis in Children: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials42
Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review41
Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature37
Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy35
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-232
Postoperative Nausea and Vomiting in Pediatric Patients30
Postoperative Pain Management in Pediatric Spinal Fusion Surgery for Idiopathic Scoliosis28
Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus26
Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient24
Immunotherapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: Advances and Ongoing Challenges21
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review20
Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents20
Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children20
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial19
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria18
An Update on CFTR Modulators as New Therapies for Cystic Fibrosis18
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study18
Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects18
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance18
0.037982940673828